Circulating tumor DNA (ctDNA) status and clinical outcomes in patients (pts) with previously untreated diffuse large B-cell lymphoma (DLBCL) in the POLARIX study.

被引：0
|
作者：
Herrera, Alex Francisco
Tracy, Samuel
Sehn, Laurie Helen
Jardin, Fabrice
Lenz, Georg
Trneny, Marek
Salles, Gilles A.
Flowers, Christopher
Tilly, Herve
Sharman, Jeff Porter
Friedberg, Jonathan W.
Balasubramanian, Sandhya
Raghavan, Vibha
Hirata, Jamie H.
Lee, Calvin
Jiang, Yanwen
Morschhauser, Franck
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] Ctr Henri Becquerel, Rouen, France
[3] Univ Rouen, Rouen, France
[4] Univ Hosp Munster, Munster, Germany
[5] Charles Univ Prague, Gen Hosp, Prague, Czech Republic
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[8] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[9] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[10] Hoffmann Roche Ltd, Mississauga, ON, Canada
[11] Univ Lille, Ctr Hosp Univ, Lille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7523
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Selinexor in Combination with R-EPOCH for Patients with Previously Untreated HIVAssociated Diffuse Large B Cell Lymphoma(DLBCL)
    Wang, Chaoyu
    Zhou, Yixing
    Zeng, Chensi
    Guo, Bingling
    Yang, Tao
    Liu, Jun
    Huang, Dehong
    Xiao, Chunyan
    Li, Jieping
    Nan, Yingyu
    Li, Qiying
    Liu, Yao
    BLOOD, 2023, 142
  • [32] Clinical significance of oxidative stress for untreated patients with diffuse large B-cell lymphoma
    Nakamura, Hiroshi
    Hara, Takeshi
    Mabuchi, Ryoko
    Matsumoto, Takuro
    Nakamura, Nobuhiko
    Ninomiya, Soranobu
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kito, Yusuke
    Takami, Tsuyoshi
    Miyazaki, Tatsuhiko
    Takeuchi, Tamotsu
    Shimizu, Masahito
    Tsurumi, Hisashi
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (01)
  • [33] Glofitamab plus Pola-R-CHP in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): Results from a phase Ib study
    Dickinson, Michael
    Viardot, Andreas
    Marks, Reinhard
    Topp, Max S.
    Morschhauser, Franck
    Jacobs, Benedikt
    Tani, Monica
    Bosch, Francesc
    Esteban, Daniel
    Cordoba, Raul
    Kaufman, Derrick
    Wu, Chun
    Humphrey, Kathryn
    Baumlin, Pauline
    Barrett, Martin
    Qayum, Naseer
    Pinto, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Dyer, Martin J. S.
    De Vos, Sven
    Ruan, Jia
    Flowers, Christopher
    Maddocks, Kami J.
    Rule, Simon
    Hamdy, Ahmed M.
    Izumi, Raquel
    Slatter, J. Greg
    Cheung, Jean
    Frigualt, Melanie M.
    Wei, Helen
    Mourya, Sanchita
    Hunder, Naomi N. H.
    Fowler, Nathan Hale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] CLINICAL FEATURES AND SURVIVAL OF PATIENTS WITH LATE RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Castillo-Giron, C.
    Rivas-Delgado, A.
    Dlouhy, I
    Rovira, J.
    Mozas, P.
    Rivero, A.
    Frigola, G.
    Balague, O.
    Baumann, T.
    Correa, J. G.
    Magnano, L.
    Jimenez-Vicente, C.
    Gomez, M.
    Delgado, J.
    Villamor, N.
    Campo, E.
    Gine, E.
    Lopez-Guillermo, A.
    HAEMATOLOGICA, 2020, 105 : 291 - 292
  • [36] Polatuzumab-R-CHP in Previously Untreated Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Bobes, Alejandro
    Llorente, Laura
    Pradillo, Virginia
    Alonso, Aranzazu
    Fernandez, Ruben
    Garcia-Noblejas, Ana
    Lopez de la Osa, M. Jose
    Casanova, Maria
    Lorente, Soraya
    Iglesias, Rebeca
    Estevez, Monica
    De Ona, Raquel
    De La Fuente, Adolfo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S479 - S479
  • [37] Prognostic Significance of Circulating Lymphoma Cells in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
    Muringampurath-John, Disni
    Flowers, Christopher R.
    Jabbar, Adrian A.
    Sinha, Rajni
    Arellano, Martha
    Bernal-Mizrachi, Leon
    Kaufman, Jonathan L.
    Jaye, David L.
    Chen, Zhengjia
    Lechowicz, Mary Jo
    Lonial, Sagar
    Armitage, James O.
    Khoury, H. Jean
    BLOOD, 2009, 114 (22) : 1151 - 1152
  • [38] Outcomes in refractory aggressive diffuse large b-cell lymphoma (DLBCL): Results from the international SCHOLAR-1 study.
    Crump, Michael
    Neelapu, Sattva Swarup
    Farooq, Umar
    Van Den Neste, Eric
    Kuruvilla, John
    Ahmed, Mohamed Amin
    Link, Brian K.
    Hay, Annette E.
    Cerhan, James Robert
    Zhu, Liting
    Boussetta, Sami
    Feng, Lei
    Maurer, Matthew John
    Navale, Lynn
    Wiezorek, Jeffrey S.
    Go, William Y.
    Gisselbrecht, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA
    Herrera, Alex F.
    Tracy, Samuel
    Croft, Brandon
    Opat, Stephen
    Ray, Jill
    Lovejoy, Alex F.
    Musick, Lisa
    Paulson, Joseph N.
    Sehn, Laurie H.
    Jiang, Yanwen
    BLOOD ADVANCES, 2022, 6 (06) : 1651 - 1660
  • [40] Risk Profiling of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients By Measuring Circulating Tumor DNA
    Herrera, Alex F.
    Tracy, Samuel
    Croft, Brandon
    Opat, Stephen
    Ray, Jill
    Musick, Lisa
    Paulson, Joseph N.
    Sehn, Laurie H.
    Jiang, Yanwen
    BLOOD, 2020, 136
12345